PARKHOSPS

Park Medi World Limited

What the six lenses say about PARKHOSPS — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹286.8
2026-09-08
VWAP · 1Y anchor
₹203
+41.2% from VWAP
P/E · TTM
48.7×
TTM EPS ₹5.9
52-week range
92%
position low→high
RSI(14)
54
momentum

Own sector index

Healthcare
Neutral

1M

-1.1%

3M

+7.1%

1Y

+14.5%

Breadth >EMA21

55%

How PARKHOSPS’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
5.0
avg conviction decile
Leadership
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Micro-cap cohortDRaw
TechnicalD553

The actual numbers

Price vs VWAP (1y)+41.2%
Price vs 50-EMA+2.7%
RSI(14)54
RS vs Nifty 500 · 3M-3.1%
RS vs sector · 3M-5.8%
52-week range92%
Volume vs 30d avg0.35×
Volume vs 60d avg0.28×
ATR(14) · volatility10.1
Bollinger width · vol contraction0.084
FundamentalD965

The actual numbers

Return on equity (ROE)12.9%
Operating margin24.4%
Net margin16.0%
Debt / equity0.18×

Full 8-quarter history in the financials table below.

ValuationD315

The actual numbers

P/E (TTM)48.7×
TTM EPS₹5.9
52-week range92%
CatalystD957

The actual numbers

Earnings & momentum46
Capital actions64
Governance86

Every filing in the corporate-announcements panel below.

FlowD550

The actual numbers

Promoter holding82.9%
Delivery · 30d avg54.6%
Up/down-day asymmetry0.5pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D5 + D5 ) ÷ 2 = 5.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Medium
52
Conviction score 52/100 · avg-decile strength 5.0/10

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+0.7pp
+1.3pp
+1.6pp
-1.5pp
+44.0pp
Nifty 500
Broad-market baseline
+0.6pp
+1.3pp
+0.6pp
-3.1pp
+38.2pp
Sector
Own-sector index
-0.8pp
-5.8pp
+29.5pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

PARKHOSPS daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
286.80+0.55

Relative strength

RS vs baseline · rebased to 100

PARKHOSPS ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
196.69+1.20

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricDec '24Mar '25Sep '25Dec '25Mar '26
Revenue (₹cr)348354410410460
↳ change QoQ+1.7%+15.8%+0.0%+12.2%
EBITDA (₹cr)838811399127
EBITDA margin23.8%24.9%27.6%24.1%27.6%
PAT (₹cr)4652795377
↳ change QoQ+13.0%+51.9%-32.9%+45.3%
Net margin13.2%14.7%19.3%12.9%16.7%
EPS (₹)2.971.171.911.171.64
D/E
YoY growth · Mar '26Revenue +32.2% YoYPAT +67.4% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 8 Sep '26
    HIGHcapital
    Acquisition

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 8 Sep '26
    LOWgovernance
    Updates

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Sep '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 31 Aug '26
    HIGHcapital
    Acquisition

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 31 Aug '26
    HIGHearnings
    Outcome of Board Meeting

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 28 Aug '26
    LOWgovernance
    General Updates

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 26 Aug '26
    LOWgovernance
    Capacity addition

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 18 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 4 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 3 Aug '26
    LOWgovernance
    Monitoring Agency Report

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 3 Aug '26
    MEDIUMearnings
    Investor Presentation

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 3 Aug '26
    MEDIUMcapital
    Press Release

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 3 Aug '26
    HIGHearnings
    Outcome of Board Meeting

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds PARKHOSPS

Mutual funds holding PARKHOSPS (10)

FundWeightAUM ₹crGrade
Kotak Multi Asset Allocation Reg Gr1.78%14,770
Kotak ELSS Tax Saver Reg Gr1.21%6,342
Kotak Infra & Econ Reform Reg Gr1.49%2,430
Helios Mid Cap Reg Gr0.73%1,951
Kotak Consumption Reg Gr3.75%1,759
ITI Mid Cap Reg Gr0.95%1,480
Helios Small Cap Reg Gr1.18%1,455
ITI Large & Mid Cap Reg Gr0.97%740
Kotak Healthcare Reg Gr3.86%682
ITI ELSS Tax Saver Reg Gr1.75%455

ETFs holding PARKHOSPS (1)

ETFWeightGrade
Groww BSE Hospitals ETF0.67%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare